170 related articles for article (PubMed ID: 15708432)
1. Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment.
Beal MF
Neurobiol Aging; 2005 May; 26(5):585-6. PubMed ID: 15708432
[No Abstract] [Full Text] [Related]
2. Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead.
Praticò D
Neurobiol Aging; 2005 May; 26(5):581-3. PubMed ID: 15708431
[No Abstract] [Full Text] [Related]
3. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
Carrillo MC; Sanders CA; Katz RG
Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
6. Mild cognitive impairment. Is it the first sign of Alzheimer's disease?
Mayo Clin Health Lett; 2001 Aug; 19(8):1-3. PubMed ID: 11475591
[No Abstract] [Full Text] [Related]
7. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
Markesbery WR; Lovell MA
Arch Neurol; 2007 Jul; 64(7):954-6. PubMed ID: 17620484
[TBL] [Abstract][Full Text] [Related]
8. Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful?
Borroni B; Di Luca M; Padovani A
Eur J Pharmacol; 2006 Sep; 545(1):73-80. PubMed ID: 16831417
[TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment, healthy aging and Alzheimer's disease.
Wu CK
Med Health R I; 2008 May; 91(5):132-3. PubMed ID: 18549037
[No Abstract] [Full Text] [Related]
10. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases.
Migliore L; Fontana I; Colognato R; Coppede F; Siciliano G; Murri L
Neurobiol Aging; 2005 May; 26(5):587-95. PubMed ID: 15708433
[TBL] [Abstract][Full Text] [Related]
11. Impaired verb fluency: a sign of mild cognitive impairment.
Ostberg P; Fernaeus SE; Hellström K; Bogdanović N; Wahlund LO
Brain Lang; 2005 Nov; 95(2):273-9. PubMed ID: 16246735
[TBL] [Abstract][Full Text] [Related]
12. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
Popp J; Schaper K; Kölsch H; Cvetanovska G; Rommel F; Klingmüller D; Dodel R; Wüllner U; Jessen F
Neurobiol Aging; 2009 Mar; 30(3):498-500. PubMed ID: 17716786
[TBL] [Abstract][Full Text] [Related]
13. Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease.
Jackson CE; Snyder PJ
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S137-43. PubMed ID: 18631990
[TBL] [Abstract][Full Text] [Related]
14. Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
Lee KS; Chung JH; Lee KH; Shin MJ; Oh BH; Hong CH
Immunol Lett; 2008 Dec; 121(2):105-9. PubMed ID: 18930766
[TBL] [Abstract][Full Text] [Related]
15. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.
Ray S; Britschgi M; Herbert C; Takeda-Uchimura Y; Boxer A; Blennow K; Friedman LF; Galasko DR; Jutel M; Karydas A; Kaye JA; Leszek J; Miller BL; Minthon L; Quinn JF; Rabinovici GD; Robinson WH; Sabbagh MN; So YT; Sparks DL; Tabaton M; Tinklenberg J; Yesavage JA; Tibshirani R; Wyss-Coray T
Nat Med; 2007 Nov; 13(11):1359-62. PubMed ID: 17934472
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
Smith JL; Xiong S; Markesbery WR; Lovell MA
Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
[TBL] [Abstract][Full Text] [Related]
17. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.
Song F; Poljak A; Smythe GA; Sachdev P
Brain Res Rev; 2009 Oct; 61(2):69-80. PubMed ID: 19464319
[TBL] [Abstract][Full Text] [Related]
18. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
[TBL] [Abstract][Full Text] [Related]
19. Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria.
Morris JC
Arch Neurol; 2006 Jan; 63(1):15-6. PubMed ID: 16401731
[No Abstract] [Full Text] [Related]
20. Clinical inquiries. Do patients at high risk of Alzheimer's disease benefit from early treatment?
Holt J; Stiltner L; Wallace R; Raetz J
J Fam Pract; 2009 Jun; 58(6):320-2. PubMed ID: 19508846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
